Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer

Clinical Trial ID NCT02673814

PubWeight™ 0.79^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02673814

Top papers